Equity
€326,651 ▼ 14.9%
KAVERO paid out €378,824 in dividends. That is 118% of the 2025 profit.
KAVERO
Lifetime
4 annual accounts with figures on one time axispeak €485,693 (2025)
€485,693▲ 7.9%
lowest -€9,361 (2022)
€321,499▲ 10.2%
peak €383,975 (2024)
€326,651▼ 14.9%
€229,813▼ 20.3%
Board2 names since 2021
1 directorVERSCHUEREN Kaat
Documentsfilings and deeds
24-07-20267 days before the deadline
2025micro format
Dividend €378,824Equity from €383,975 to €326,651Debts from €288,396 to €229,813Cash from €215,181 to €53,975
Key points
from the 2025 annual accountsTurnover
≈ €750,000 estimated
The micro format states no turnover.
Staff
1 employees on 31-12-2025
In 2025, 1 person joined and nobody left.
Liquidity
7.87 was 4.59 in 2024
Short-term debts fell from €93,322 to €44,571.
Filings
4 annual accounts 1 late
The 2022 accounts came 30 days late. The other three were filed on time.
Position in the sector
€321,499
Higher net result than 95% of companies in human health. Sector median €60,070 · 20,754 companies.
Checked score
93
Excellent
Financially stronger than 48% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025lowest value
12-2025: < 0.1%● unchanged vs 11-2025lowest value
01-2026: < 0.1%● unchanged vs 12-2025lowest value
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026highest value
11-2026: < 0.1%● unchanged vs 10-2026highest value
Financial strengthStrong
Score breakdown
raises risk
Founded in 2021
lowers risk
Sector: Human health activities (NACE 86)
Size: total assets €556,463
Figures for financial year 2025 (filed on 24-07-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 47% of them on solvency, 40% on liquidity, 80% on profitability and 24% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 39,278 companies had the same profile as KAVERO has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of KAVERO itself is lower: < 0.1% within 12 months. It rests on far more data about KAVERO than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for KAVERO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €30,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 7.87 (4.59 in 2024), above the usual 1.5. Short-term debt is 8% and cash 9.7% of total assets. 41.3% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
7 days early
2024
18 days early
2023
2 days early
2022
30 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 4 accounts on average 1 day after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 July (3 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0777500431
Incorporation
Founding capital of €5,000, 100 shares · Founder: VERSCHUEREN Kaat · Appointments: VERSCHUEREN Kaat (director) and Leo Frans Verschueren (successor director) · published on 23-11-2021 · Gazette deed
First establishment
Poststraat 10, Putte
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| KAVERO Putte | €556,463 | €485,693 | 58.7% | - |
| Dentiste Damoiseau Clémentine Philippeville | €515,148 | €468,078 | 20.5% | - |
| FIRST SMILE Rixensart | €515,576 | €465,178 | 58.2% | - |
| BIYOU Beersel | €576,746 | €523,630 | 45.8% | - |
| CAPARO Deinze | €579,841 | €439,167 | 98.9% | - |
| Dadident Moorslede | €623,585 | €437,588 | 37.0% | - |
| TIJS LAMBRECHTS Ghent | €700,296 | €466,107 | 45.1% | - |
These companies have the same main activity as KAVERO: dental practice (NACE 86230). They are comparable in size and age: total assets between €515,000 and €700,000, founded between 2021 and 2022.
Official details
Source: KBO- Status
- Active since 19-11-2021Normal situation
- Activity
- Dental practiceNACE 86230
- Joint committee
- 330Health institutions and services · annual accounts 2024
- Establishment unit
- 2.325.675.9582580 Putte, since 19-11-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 28-07-2024
Annual accounts 2025
- €556,463▼ 17.2%
- Employeeson 31-12-2025
- 1=
- Filing
- Filed on 24-07-2026, 7 days before the end of the filing period
Insights on KAVERO
KAVERO files the micro format. That format states no turnover. The gross margin rose from €7,014 in 2022 to €485,693 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about KAVERO
- What is the company number of KAVERO?
- The company number of KAVERO is 0777.500.431. The VAT number is the same number with BE in front: BE 0777.500.431.
- Where is KAVERO based?
- The registered office is at Poststraat 10, 2580 Putte.Company details
- What does KAVERO do?
- According to the KBO register, the main activity is dental practice (NACE 86230).
- What is the legal form of KAVERO?
- KAVERO is a private limited company (BV).
- When was KAVERO founded?
- KAVERO was founded on 19-11-2021.
- Is KAVERO still active?
- Yes, KAVERO is an active enterprise in the KBO register.
- How many employees does KAVERO have?
- KAVERO had an average of 1.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does KAVERO fall under?
- In its 2024 annual accounts, KAVERO states joint committee 330 (Health institutions and services).
- What is the turnover of KAVERO?
- The turnover in financial year 2025 is ≈ €750,000. This figure is estimated from the gross margin of €485,693 and 37 comparable companies (NACE 862). It probably lies between €660,000 and €940,000.
- Is KAVERO profitable?
- In financial year 2025, KAVERO made a profit of €321,499.
- Where can I find the annual accounts of KAVERO?
- KAVERO filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of KAVERO due?
- KAVERO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.